OTC · KALY
Kali, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Oct 9, 2026, 3:36 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 50.91K
- P/E ratio
- -4.28
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 16.4K
- Avg. volume
- 199.65K
Price performance · KALY
KALY price history
1M range · 0 trading sessions · Daily adjusted prices
KALY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest KALY news
The latest Smart Investors Daily articles mentioning KALY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
KALY research
Overview
Company profile and research snapshot.
Company profile
KALI INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
